US stock futures mixed, Franklin Covey Co drops 19.7% after lowering revenue guidance. Other stocks

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered L

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims

RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in mode

LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litiga

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

LOS ANGELES, June 8, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigat

Certara NASDAQ: CERT executives outlined the company's strategic realignment, artificial intelligenc

NEW YORK, June 4, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves

Cerrado Gold Inc. (CERT:CA) Q1 2026 Earnings Call Transcript

Ahead of hurricane season, Duke Energy Foundation awards $500,000 to strengthen storm preparedness a

NEW YORK, May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of invest

LOS ANGELES, May 24, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights lit

Craig-Hallum analyst Matthew Hewitt maintains Certara (NASDAQ:CERT) with a Hold and lowers the pr

BMO Capital analyst Sean Dodge maintains Certara (NASDAQ:CERT) with a Market Perform and lowers t

Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers the

Stephens & Co. analyst Jeff Garro maintains Certara (NASDAQ:CERT) with a Overweight and lower

Morgan Stanley analyst Sean Laaman maintains Certara (NASDAQ:CERT) with a Equal-Weight and lowers

Baird analyst Joe Vruwink maintains Certara (NASDAQ:CERT) with a Neutral and lowers the price tar

Small caps lead a mixed Wall Street session as Trump rejects Iran's peace response, sending crud

Certara (NASDAQ:CERT) lowers FY2026 Adj EPS guidance from $0.44-$0.48 to $0.35-$0.41 vs $0.45 analys

Certara (NASDAQ:CERT) reported quarterly earnings of $0.09 per share which missed the analyst consen

Altasciences, a fully integrated drug development solution company, andCertara (NASDAQ:CERT), a glob

Certara stock rises after $135 million divestiture to Veristat as analysts weigh MIDD focus and impr

Keybanc analyst Brandon Nispel maintains Certara (NASDAQ:CERT) with a Overweight and lowers the p

Barclays analyst Luke Sergott downgrades Certara (NASDAQ:CERT) from Overweight to Equal-Weight an

Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Overweight and lowers the pr

Certara (NASDAQ:CERT) reported quarterly earnings of $0.09 per share which missed the analyst consen

Keybanc analyst Scott Schoenhaus maintains Certara (NASDAQ:CERT) with a Overweight and lowers the

Leerink Partners analyst Michael Cherny upgrades Certara (NASDAQ:CERT) from Market Perform to Out

Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive p

Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TL